Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) settled +4.4% in Frankfurt trading Thursday as Goldman Sachs upgraded shares to Buy from ...

Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price ...

Find insight on Bayer and more in the latest Market Talks covering the Health Care sector.

Investing.com -- Shares of Bayer AG (ETR: BAYGN) were up over 5% on Thursday after Goldman Sachs upgraded the German pharmaceutical and life sciences company to a "buy" rating from "neutral ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

On Thursday, Goldman Sachs analysts upgraded Bayer AG (ETR:BAYGN) (BAYN:GR) (OTC: BAYRY) stock from Neutral to Buy. The new price target is set at €33.00, up from the previous €29.10.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) settled +4.4% in Frankfurt trading Thursday as Goldman Sachs upgraded shares to Buy from neutral with a €33 price target, raised from €29.10 previously ...